Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
Antony
S J
SJ
Texas Oncology Physicians Associates, El Paso Cancer Treatment Center, El Paso, Texas 79915, USA. santony999@aol.com
Bitter
K M
KM
Moreland
T
T
Raudales
F
F
Diaz-Luna
H
H
D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D010080:Oxazoles / Q000627:therapeutic use*; D023303:Oxazolidinones; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014184:Transplantation, Homologous
D000081:Acetamides; D000890:Anti-Infective Agents; D010080:Oxazoles; D023303:Oxazolidinones; D000069349:Linezolid